Spi-1 is a putative oncogene in virally induced murine erythroleukaemias
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Retroviral insertional mutagenesis has been proposed as an efficient mechanism to turn on or to increase the expression of oncogenes in several avian or mammal models. Integration site studies of avian leukosis virus, murine leukaemia and murine mammary tumour viruses led to the coleutification of highly conserved genes whose expression is induced or increased during leukaemogenesis, probably through enhancer elements present in the retroviral long terminal repeats. This is reminiscent of the activation of cellular proto-oncogenes or putative oncogenes in numerous human tumours and leukaemias as a result of chromosomal translocations or DNA rearrangements. Here we report the characterization of a new putative oncogene isolated from a murine erythroleukaemia induced by the acute leukaemogenic retrovirus spleen focus forming virus (SFFV). An important and unusual feature of this genomic locus Spi-1 (for SFFV proviral integration) is that rearrangements due to SFFV integration were found in 95% of the erythroid tumours studied. A 4.0-kilobase messenger RNA was detected in rearranged tumours. No Spi-1 rearrangement was detected in other virally induced myeloid, lymphoid or erythroid tumours tested.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aberrant expression of PU.1 inhibits erythroid cell differentiation and contributes to the formation of murine erythroleukemias (MEL).”
From Inhibition of CBP-Mediated Protein Acetylation by the Ets Family Oncoprotein PU.1 (2002) · cites this paper as [50]
In the citing paper
“However, CellOracle did not detect a previously reported depletion of erythrocyte progenitors after Spi1 KO27,28, probably owing to changes in cell proliferation that are not predicted by the method.”
From Dissecting cell identity via network inference and in silico gene perturbation (2023) · cites this paper as [28]
In the citing paper
“PU.1 (Spi-1), a member of this family, is encoded by proto-oncogene sfpi-1 and is expressed exclusively in haematopoietic cells, with high levels detected in monocytic, granulocytic and B lymphoid lineages [16–20].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [16]
In the citing paper
“PU.1 is an Ets-family transcription factor which controls many critical genes important for the development of white cells within the hematopoietic system, in particular, myeloid and B cells”
From Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element (2005) · cites this paper as [34]
In the citing paper
“The SFFV provirus integration sites span several kilobases approximately 14 kb 5Ј of the PU.1 coding region (34,44).”
From Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element (2005) · cites this paper as [34]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Nusse, R., & Varmus, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,863
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
Hayward, W. S., Neel, B. G., & Astrin, S. M. (1981) · Nature · doi:10.1038/290475a0 · Cited by 1,567
Theo Cuypers, H., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., van Wezenbeek, P., Melief, C., & Berns, A. (1984) · Cell · doi:10.1016/0092-8674(84)90309-x · Cited by 639
Novel bacteriophage lambda cloning vector.
Karn, J., Brenner, S., Barnett, L., & Cesareni, G. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5172 · Cited by 386
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus
Mowat, M., Cheng, A., Kimura, N., Bernstein, A., & Benchimol, S. (1985) · Nature · doi:10.1038/314633a0 · Cited by 320
Peters, G., Brookes, S., Smith, R., & Dickson, C. (1983) · Cell · doi:10.1016/0092-8674(83)90418-x · Cited by 320
Fung, Y.-K. T., Lewis, W. G., Crittenden, L. B., & Kung, H.-J. (1983) · Cell · doi:10.1016/0092-8674(83)90417-8 · Cited by 281
Activation of the c- myb Locus by Viral Insertional Mutagenesis in Plasmacytoid Lymphosarcomas
Shen-Ong, G. L. C., Potter, M., Mushinski, J. F., Lavu, S., & Reddy, E. P. (1984) · Science · doi:10.1126/science.6093260 · Cited by 143
Specific integration of REV proviruses in avian bursal lymphomas
Noori-Daloii, M.-R., Swift, R. A., Kung, H.-J., Crittenden, L. B., & Witter, R. L. (1981) · Nature · doi:10.1038/294574a0 · Cited by 130
Linemeyer, D. L., Menke, J. G., Ruscetti, S. K., Evans, L. H., & Scolnick, E. M. (1982) · Journal of Virology · doi:10.1128/jvi.43.1.223-233.1982 · Cited by 110
Cited by
Items 301–400 of 454
Kihara-Negishi, F., Suzuki, M., Yamada, T., Sakurai, T., & Oikawa, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.098 · Cited by 15
Liu, C., Qiu, X., Gao, J., Gong, Z., Zhou, X., Luo, H., & Geng, X. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17844 · Cited by 13
Mouse Models for Efficacy Testing of Agents against Radiation Carcinogenesis — A Literature Review
Rivina, L., & Schiestl, R. H. (2012) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10010107 · Cited by 16
“It’s essential for terminal myeloid (macrophages and neutrophils) cell differentiation and stem cell maintenance [83–87].”
BackgroundTranscriptional Factor PU.1 Regulates Decidual C1q Expression in Early Pregnancy in Human
Madhukaran, S. P., Kishore, U., Jamil, K., Teo, B. H. D., Choolani, M. A., & Lu, J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00053 · Cited by 13
“1, an Ets-family transcription factor, was originally shown to be transcriptionally up-regulated in murine erythroleukemia following proviral integration of “spleen focus forming virus” (SFFV) (known as SP11) in humans (10, 11).”
BackgroundInfluentialYamada, T., Suzuki, M., Satoh, H., Kihara‐Negishi, F., Nakano, H., & Oikawa, T. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.10.023 · Cited by 14
He, S., Ni, S., Hegde, S., Wang, X., Sharda, D. R., August, A., Paulson, R. F., & Hankey, P. A. (2009) · Journal of Virology · doi:10.1128/jvi.02090-09 · Cited by 13
“The late stage of erythroleukemia in Friend disease is marked by inactivation of the p53 locus (6, 28, 38, 39, 51) and proviral integration into the Spi-1 locus (36, 43, 44), resulting in enhanced expression of Pu.”
BackgroundPU.1 is a major transcriptional activator of the tumour suppressor geneLIMD1
Foxler, D. E., James, V. H., Shelton, S. J., Vallim, T. Q. D. A., Shaw, P. E., & Sharp, T. V. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.013 · Cited by 18
“1, also referred to as spleen focus forming virus proviral integration protein (Spi1), was first identified as a putative oncogene in murine erythroleukaemias [15].”
BackgroundD’Andrea, A. D., Moreau, J., & Showers, M. O. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(92)90004-i · Cited by 14
The murine AIDS defective provirus acts as an insertional mutagen in its infected target B cells
Huang, M., Takáč, M., Kozak, C. A., & Jolicoeur, P. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4069-4078.1995 · Cited by 16
“The putative oncogene identity of Spi-1 was strongly suggested by the rearrangement of this locus in 95% of the virus-induced erythroid tumors (42).”
BackgroundInfluentialMoreau-Gachelin, F. (2006) · PubMed · Cited by 18
Self-citationVecchiarelli-Federico, L. M., Liu, T., Yao, Y., Gao, Y., Li, Y., Li, Y., & Ben‐David, Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4027 · Cited by 13
“1 in SFFV-induced erythroleukemia (6), and fli‐1, in F-MuLV-induced erythroleukemia (7,8).”
Copeland, N. G., Buchberg, A. M., Gilbert, D. J., & Jenkins, N. A. (1989) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-74623-9_4 · Cited by 12
Interferon Induces Up-regulation of Spi-1/PU.1 in Human Leukemia K562 Cells
Gutiérrez, P., Delgado, M. D., Richard, C., Moreau-Gachelin, F., & León, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7760 · Cited by 13
Self-citationGenomic organization of the human e1af gene,a member of Ets transcription factors
Coutte, L., Monté, D., Baert, J., & de Launoit, Y. (1999) · Gene · doi:10.1016/s0378-1119(99)00400-x · Cited by 12
Detection of HIV in human vitreous
Mietz, H., Heimann, K., K�hn, J., Wieland, U., & Eggers, H. J. (1993) · International Ophthalmology · doi:10.1007/bf00942783 · Cited by 12
Yamada, T., Shimizu, T., Suzuki, M., Kihara‐Negishi, F., Nanashima, N., Sakurai, T., Yang, F., Akita, M., Oikawa, T., & Tsuchida, S. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.11.005 · Cited by 12
Koury, M. J., Park, D. J., Martincic, D., Horne, D. W., Kravtsov, V., Whitlock, J. A., Aguinaga, M. D. P., & Kopsombut, P. (1997) · Blood · doi:10.1182/blood.v90.10.4054 · Cited by 11
Reprogramming erythroleuekmia cells to terminal differentiation and terminal cell division
Matushansky, I. (2000) · Frontiers in bioscience · doi:10.2741/matushan · Cited by 11
Copeland, N. G., & Jenkins, N. A. (1990) · Advances in cancer research · doi:10.1016/s0065-230x(08)60810-6 · Cited by 11
BHAT, N. K., & Papas, T. S. (1992) · Hybridoma · doi:10.1089/hyb.1992.11.277 · Cited by 12
Ghysdael, J., & Yaniv, M. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90077-c · Cited by 12
Beug, H., Metz, T. M., Müllner, E., & Hayman, M. J. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_4 · Cited by 12
Pin1‐Mediated Prolyl Isomerization of Runx1 Affects PU.1 Expression in Pre‐Monocytes
Islam, R., Yoon, W., Woo, K. M., Baek, J., & Ryoo, H. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24462 · Cited by 11
“The overexpression of PU.1 in transgenic mice leads to erythroleukemia (MoreauGachelin et al., 1996).”
BackgroundMolecular Landscapes and Models of Acute Erythroleukemia
Fagnan, A., Piqué‐Borràs, M., Tauchmann, S., Mercher, T., & Schwaller, J. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000558 · Cited by 11
Petit, F. G., Salas, R., Tsai, M., & Tsai, S. Y. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.03.009 · Cited by 13
Tsuji-Kawahara, S., Kawabata, H., Matsukuma, H., Kinoshita, S., Chikaishi, T., Sakamoto, M., Kawasaki, Y., & Miyazawa, M. (2013) · Journal of Virology · doi:10.1128/jvi.02506-13 · Cited by 10
“1 (in 4 out of the 10 mice) (Table 1), which were reported previously as major targets for integration of F-MuLV or SFFV proviruses in erythroleukemia cell lines established from FV-susceptible mice (3, 39).”
BackgroundTranscription Factors Mediating Interleukin‐3 Survival Signals
Yen, J. J., & Yang‐Yen, H. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74006-7 · Cited by 10
Hasegawa, M., Yamaguchi, S., Aizawa, S., Ikeda, H., Tatsumi, K., Noda, Y., Hirokawa, K., & Kitagawa, M. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.01.016 · Cited by 10
Hasenkrug, K. J., Sprangrude, G. J., Nishio, J., Brooks, D. M., & Chesebro, B. W. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2059-2064.1994 · Cited by 10
“This acute proliferation is followed by the immortalization of cells having SFFV proviral integrations at the Spi-1 cellular oncogene locus (29, 31).”
BackgroundStarck, J., Mouchiroud, G., Gonnet, C., Mehlen, A., Aubert, D., Dorier, A., Godet, J., & Morlé, F. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00006-5 · Cited by 10
Howard, J. C., Li, Q., Chu, W., Zochodne, B., Kapoor, M., Ung, Y., Rosen, K. V., & Ben‐David, Y. (2001) · Oncogene · doi:10.1038/sj.onc.1204348 · Cited by 10
“Isolation of several SFFVhost junction fragments resulted in the identi®cation of a locus termed Spi-1 (SFFV proviral integration 1), which is rearranged in 95% of erythroleukemias induced by either FV-P or FV-A (Moreau-Gachelin et al., 1988).”
BackgroundThe role of gp55 N-glycosylation in pathogenesis of Friend spleen focus-forming virus
Rau, S., Geyer, R., & Friedrich, R. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-4-699 · Cited by 10
SPI-1 transforming properties depend upon specifically activated forms of the EPOR
Pereira, R. M., Raingeaud, J., Pironin, M., Ghysdael, J., & Quang, C. T. (2000) · Oncogene · doi:10.1038/sj.onc.1203886 · Cited by 10
Afrikanova, I., Yeh, E., Bartos, D., Watowich, S. S., & Longmore, G. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205183 · Cited by 10
“In Friend erythroleukemia cells integration of an SFFV provirus in the PU.1 gene locus is thought to activate transcription of PU.1 (Moreau-Gachelin et al., 1988; Moreau-Gachelin et al., 1989; Paul et al., 1991).”
BackgroundThe making of an erythroid cell: Molecular control of hematopoiesis
Migliaccio, A. R., & Migliaccio, G. (1998) · Biotherapy · doi:10.1007/bf02678546 · Cited by 13
Kwok, J. C., Perdomo, J., & Chong, B. H. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21264 · Cited by 12
“As numerous diseases have been attributed to the mis-localization of transcription factors including SHOX, Tbx1, Tbx5 as well as AML1 [Reamon-Buettner and Borlak, 2004; Sabherwal et al., 2004; Stoller and Epstein, 2005; Vradii et al., 2005], it is possible that missense mutations in the NLS of Ets transcription factor…”
BackgroundInfluentialNuclear Factors That Regulate Erythropoiesis
Blobel, G. A., & Weiss, M. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.008 · Cited by 9
Laget, M.-P., Callebaut, I., de Launoit, Y., Stéhelin, D., & Mornon, J. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.25.5987 · Cited by 9
Transcription factor encoding oncogenes
Lucibello, F. C., & Müller, R. (1992) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/3540551921_8 · Cited by 9
Shoji, W., Ohmori, Y., & Obinata, M. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb02062.x · Cited by 9
Kao, S., Miyagi, E., Mallorson, R., Saito, H., Sukegawa, S., Mukherji, A., Mateja, A., Ferhadian, D., Fabryova, H., Clouse, K., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00652-22 · Cited by 8
“a putative oncogene encoded by the Spi-1 locus, which was associated with virally induced murine erythroleukemia (20).”
BackgroundKorczmar, E., Bookstaver, A. K., Ober, E., Goldfarb, A. N., Tenen, D. G., & Trinh, B. Q. (2024) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1602010 · Cited by 9
“In mice, the spleen focus forming virus (SFFV), which integrates into the URE in a site flanking the two conserved H1 and H2 regions, is implicated in causing Friend virus-induced erythroleukemia [1,2,67].”
BackgroundTranscriptomic and proteomic analysis of mouse radiation-induced acute myeloid leukaemia (AML)
Badie, C., Blachowicz, A., Barjaktarović, Ž., Finnon, R., Michaux, A., Sarioglu, H., Brown, N., Manning, G., Benotmane, M. A., Tapio, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9626 · Cited by 11
Expression profile of PU.1 in CD4+T cells from patients with systemic lupus erythematosus
Xiang, N., Fang, X., Sun, X.-G., Zhou, Y., Ma, Y., Chen, Z., Li, X.-P., Wang, G., Tao, J., & Li, X. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00717-9 · Cited by 10
“The SPI1 gene is located on human chromosome 11p11 and is regulated through the proximal promoter and upstream regulatory element located 17 kb upstream of the transcription start site [5].”
BackgroundRNA-binding proteins as drivers of AML and novel therapeutic targets
Qin, T., Cheng, Y., & Wang, X. (2022) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.2008381 · Cited by 8
“1 to induce Friend erythroleukemia [107].”
Role of Phosphatidylinositol 3-Kinase in Friend Spleen Focus-Forming Virus-Induced Erythroid Disease
Umehara, D., Watanabe, S., Ochi, H., Anai, Y., Ahmed, N., Kannagi, M., Hanson, C. A., Ruscetti, S. K., & Nishigaki, K. (2010) · Journal of Virology · doi:10.1128/jvi.00488-10 · Cited by 8
Luo, M., Shang, J., Yang, Z., Simkevich, C. P., Jackson, C. L., King, T. C., & Rosmarin, A. G. (1999) · Gene · doi:10.1016/s0378-1119(99)00167-5 · Cited by 9
Cell Cycle Regulation and Erythroid Differentiation
Müllner, E., Dolznig, H., & Beug, H. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80057-3_15 · Cited by 9
Analysis of the 5′ promoters for human IL-3 and GM-CSF receptor α genes
Akagawa, E., Muto, A., Arai, K., & Watanabe, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02890-5 · Cited by 10
Kennedy, M. A., Beug, H., Wagner, E. F., & Keller, G. M. (1992) · Blood · doi:10.1182/blood.v79.1.180.180 · Cited by 8
Nibbs, R. J. B., Itoh, K., Ostertag, W., & Harrison, P. R. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5582 · Cited by 10
González‐Vallinas, J., Pagès, A., Singh, B., & Eyras, E. (2015) · BMC Genomics · doi:10.1186/s12864-015-1704-0 · Cited by 7
“This result suggests the interesting possibility that the binding of PU.1 to an enhancer inside the MACF1 gene may affect its splicing, thereby altering Wnt signaling and contributing to the oncogenic transformation associated to PU.1 [53].”
BackgroundPU.1, a Shared Transcriptional Regulator of Innate and Adaptive Immune Cell Fates
Singh, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1595 · Cited by 7
Petrák, J., Myslivcová, D., Man, P., Čmejlová, J., Čmejla, R., & Vyoral, D. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.10.007 · Cited by 7
Nemoto, Y., Terajima, M., Shoji, W., & Obinata, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13542 · Cited by 8
PU.1 Is Degraded in Differentiation of Erythrocytes Through a Proteasome-Dependent Pathway
Konishi, Y., & Tominaga, A. (2006) · DNA and Cell Biology · doi:10.1089/dna.2006.25.340 · Cited by 6
“T HE ONCOGENE Spi-1/PU.1 was originally identified as a genomic locus rearranged by spleen focus-forming proviral insertion in most of the malignant erythroblastic tumor cells (Moreau-Gachelin et al ., 1988).”
Role of the SPI1/CDKN2A/p53 signaling pathway in cuproptosis of lung adenocarcinoma cells
An, J., Song, W., Wang, Q., Tan, B., Fei, X., Wang, R., Li, S., Lu, X., Li, Y., & Xie, N. (2025) · Oncology Letters · doi:10.3892/ol.2025.15099 · Cited by 6
“It was initially isolated by Moreau‑Gachelin et al (49) from Friend erythroleu‑ kemia and belongs to the erythroblast transformation‑specific family of TFs. Prior studies have demonstrated the tumor suppressor role of SPI1 in classical Hodgkin lymphoma cells and non‑Hodgkin lymphoma cells by modulating the cell cycle…”
Pawlikowska, P., Delestré, L., Gregoricchio, S., Oppezzo, A., Esposito, M., Diop, M. K., Rosselli, F., & Guillouf, C. (2023) · Oncogene · doi:10.1038/s41388-023-02800-9 · Cited by 6
Mouse Models of Human Blood Cancers: Basic Research and Pre-clinical Applications
Li, S. (2008) · Springer eBooks · doi:10.1007/978-0-387-69132-9 · Cited by 6
Effect of purine-rich box1 on proliferation of fibroblasts
Lu, K., Du, H., Lian, A., Su, Y., & Wang, F. (2020) · International Journal of Ophthalmology · doi:10.18240/ijo.2020.11.22 · Cited by 6
Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia
Mueller, B. U., Pabst, T., Hauser, P., Gilliland, G. D., Neuberg, D. S., & Tenen, D. G. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603198 · Cited by 7
The Role of Ets Transcription Factors in Mediating Cellular Transformation
Foos, G., & Hauser, C. A. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18932-6_8 · Cited by 6
“tivated by Friend spleen focus forming virus insertion (Moreau-Gachelin et al. 1988).”
BackgroundMethodThe Role of DCT/TYRP2 in Resistance of Melanoma Cells to Drugs and Radiation
Pak, B. J., & Ben‐David, Y. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-994-3_32 · Cited by 6
Subramanian, A., Hegde, S., Correll, P. H., & Paulson, R. F. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.02.006 · Cited by 6
Kondoh, N., Yamada, T., Kihara‐Negishi, F., Yamamoto, M., & Oikawa, T. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.567 · Cited by 8
Shimada, Y., Migliaccio, G., Ruscetti, S. K., Adamson, J., & Migliaccio, A. (1992) · Blood · doi:10.1182/blood.v79.9.2423.2423 · Cited by 6
Multi-omics joint screening of biomarkers related to M2 macrophages in gastric cancer
Wang, X., & Zhang, Y. (2024) · Discover Oncology · doi:10.1007/s12672-024-01623-8 · Cited by 6
Brown, N., Finnon, R., Finnon, P., McCarron, R., Cruz-Garcia, L., O’Brien, G., Herbert, E., Scudamore, C. L., Morel, E., & Badie, C. (2023) · iScience · doi:10.1016/j.isci.2023.107530 · Cited by 5
Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemia
Haeri, M., Li, Y., Li, Y., Li, Q., Spaner, D., & Ben‐David, Y. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1943 · Cited by 5
Scolan, E. L., Wendling, F., Barnache, S., Denis, N., Tulliez, M., Vainchenker, W., & Moreau-Gachelin, F. (2001) · Oncogene · doi:10.1038/sj.onc.1204708 · Cited by 5
“The blots were hybridized with the ecotropic F-MuLV viral env probe (MoreauGachelin et al., 1983) and washed as previously described (Moreau-Gachelin et al., 1988).”
MethodSelf-citationFriend Virus‐Induced Erythroleukemia: A Multistage Malignancya
David, Y. B., & Bernstein, A. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb16468.x · Cited by 5
Subunit Structure and Transmembrane Signaling of the Erythropoietin Receptor
Showers, M. O., & D’Andrea, A. D. (1993) · International review of cytology · doi:10.1016/s0074-7696(08)62601-7 · Cited by 5
Han, X. D., Wong, P., & Chung, S. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10129 · Cited by 5
Paulson, R. F., & Bernstein, A. (1998) · Mammalian Genome · doi:10.1007/s003359900774 · Cited by 5
“activation by proviral insertion of either Sfpil or Flil, members of the ets family of transcription factors (Ben-David et al. 1991; Moreau-Gachelin et al. 1988).”
BackgroundRegeneration alters open chromatin andcis-regulatory landscape of erythroid precursors
Zhou, Y., Dogiparthi, V. R., Harris, H. L., Ray, S., Choudhuri, A., Yang, S. P., Zhou, Y., Zon, L. I., Rowley, M. J., & Hewitt, K. J. (2025) · Genome Research · doi:10.1101/gr.279949.124 · Cited by 5
Teal, H. E., Craici, A. C., Paulson, R. F., & Correll, P. H. (2003) · Stem Cells and Development · doi:10.1089/152581603321628313 · Cited by 4
“Subsequent mutations in p53 combined with transcriptional activation of the Ets family, Fli-1 and Spi-1 , results in the progression of erythroleukemia (19,20).”
Smits, R., Hofland, N., Edelmann, W., Geugien, M., Jagmohan-Changur, S., Albuquerque, C., Breukel, C., Kucherlapati, R., Kielman, M. F., & Fodde, R. (2000) · Genes, Chromosomes and Cancer · doi:10.1002/1098-2264(2000)9999:9999<::aid-gcc1033>3.0.co;2-r · Cited by 91
Muenchau, D. D., Ruscetti, S. K., & Anderson, W. F. (1992) · Virology · doi:10.1016/0042-6822(92)90070-6 · Cited by 4
Shen, L., Tenzer, S., Hess, M., Distler, U., Tubbe, I., Montermann, E., Schimmer, S., Dittmer, U., Grabbe, S., & Bros, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192541 · Cited by 3
To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice
Genua, C. D., & Nerlov, C. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.02.006 · Cited by 3
Vagal-mAChR4 signaling promotes Friend virus complex (FV)-induced acute erythroleukemia
Song, S., Lin, Z., Zhao, C., Wen, J., Chen, J., Xie, S., Qi, H., Wang, J., & Su, X. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.05.005 · Cited by 4
“(Moreau-Gachelin et al., 1988), our data indicates mAChR4-SPI1 signaling may regulate the development of acute erythroleukemia.”
BackgroundDecreased PU.1 expression in mature B cells induces lymphomagenesis
Endo, S., Nishimura, N., Toyoda, K., Komohara, Y., Carreras, J., Yuki, H., Shichijo, T., Ueno, S., Ueno, N., Hirata, S., et al. (2024) · Cancer Science · doi:10.1111/cas.16344 · Cited by 4
Murine Models of Hematopoietic Disease: Pathologic Analysis and Characterization
Lee, B. H., & Kutok, J. L. (2008) · Springer eBooks · doi:10.1007/978-0-387-69132-9_3 · Cited by 3
PU.1, a Versatile Transcription Factor and a Suppressor of Myeloid Leukemia
Takahashi, S. (2011) · InTech eBooks · doi:10.5772/25853 · Cited by 3
“in 95% of the erythroid tumors examined (Moreau-Gachelin et al., 1988).”
BackgroundImmortalisation érythrocytaire pour production de globules rouges in vitro
Caulier, A., Guyonneau-Harmand, L., & Garçon, L. (2017) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2017.06.030 · Cited by 3
“[9] Moreau-Gachelin F, Tavitian A, Tambourin P.”
Hall, A. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-74778-6_10 · Cited by 3
Macpherson, G. R., Hanson, C. A., Thompson, D. M., Perella, C. M., Cmarik, J. L., & Ruscetti, S. K. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.08.019 · Cited by 2
Deregulation of Signal Transduction Pathways by Oncogenic Retroviruses
Ruscetti, S. K., & Cmarik, J. L. (2010) · Springer eBooks · doi:10.1007/978-0-387-09581-3_3 · Cited by 3
Thomson, A. M., Roberts, N. A., & Wood, W. G. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00864.x · Cited by 2
“…analysis was performed using standard methods (Southern, 1975; Sambrook et al, 1989) with the following probes: Pst I-Pst I murine spi-1 probe A (Moreau-Gachelin et al, 1988); Hind III-Bgl II mouse p53 cDNA (Jenkins et al, 1984); EcoR I-EcoR I mouse fli-1 B1 and EcoR I-EcoR I mouse fli-1 B2…”
BackgroundMethodGene transfer in situ and in cells for intracerebral transplantation
Horellou, P., Lundberg, C., Robert, J.-J., Björklund, A., & Mallet, J. J. (1993) · Seminars in Neuroscience · doi:10.1016/s1044-5765(05)80017-x · Cited by 2
Batista, C. R., & DeKoter, R. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101960 · Cited by 2
The Role of PU.1 in the Regulation of Lymphoid and Myeloid Hematopoietic Progenitors
Scott, E. W. (1998) · Humana Press eBooks · doi:10.1007/978-1-4757-2778-4_7 · Cited by 1
A novel zinc finger gene, ZNF465, is inappropriately expressed in acute myeloid leukaemia cells
Collin, J. F., Wells, J. W., Czepulkowski, B. H., Lyne, L., Duriez, P. J., Banham, A. H., Mufti, G. J., & Guinn, B. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22242 · Cited by 2
Function of c‐mycon erythroid differentiation and heme synthesis
Obinata, M., Ohmori, Y., Takada, S., & Shoji, W. (1994) · Stem Cells · doi:10.1002/stem.5530120708 · Cited by 1
Molecular Regulation of Granulopoiesis
Kumar, S., & Filippi, M. (2013) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781848168374_0001 · Cited by 1
THE MOLECULAR, CELLULAR, AND GENETIC BASIS OF HEMOGLOBIN DISORDERS
Steinberg, M. H., Forget, B. G., Higgs, D. R., & Weatherall, D. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596582.004 · Cited by 1
Koschmieder, S., & Serve, H. L. (2007) · Wiley eBooks · doi:10.1002/9780470025079.chap387 · Cited by 1
“Chronic myelogenous leukaemia BCR-ABL positive (reviewed in Wong and Witte (2001), Ren (2005), Cuenco and Ren (2004), Dash et al.”
BackgroundSynergism Between Oncogenes in T-cell Lymphomagenesis
Berns, A. J. M., Breuer, M. L., Verbeek, S. J., & van Lohuizen, M. (1989) · Springer eBooks · doi:10.1007/978-3-642-74197-5_31 · Cited by 1
Armand Tavitian (1931-2020): Des oncogènes à la superfamille Ras
Moreau-Gachelin, F., Camonis, J., de Gunzburg, J., & Goud, B. (2020) · médecine/sciences · doi:10.1051/medsci/2020136 · Cited by 1
Self-citationThe role of CD4+ T cells in Friend virus infection
Pike, R. (2011) · UCL Discovery (University College London)
Metadata
- Authors
- Moreau-Gachelin, F., Tavitian, A., & Tambourin, P.
- Affiliations
- Inserm (FR)
- Venue
- Nature
- Published
- 1988-01
- Volume
- 331
- Issue
- 6153
- Pages
- 277-280
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1975584136
- Cited by
- 447
- References
- 26
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 8 · 2020: 7 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 6 · 2015: 8 · 2014: 7 · 2013: 10 · 2012: 11
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Keywords
- SPI-1, spleen focus-forming virus, retroviral insertional mutagenesis, retroviral integration, chromosomal rearrangements, avian leukosis virus, murine leukemia virus, retroviral oncogenesis
- MeSH terms
- Animals, Cell Transformation, Viral, DNA, Neoplasm, DNA, Viral, Leukemia, Erythroblastic, Acute, Friend murine leukemia virus, Leukemia, Experimental, Mice, Inbred CBA, Mice, Inbred DBA, Leukemia Virus, Murine, Oncogenes, Proviruses, RNA, Messenger, RNA, Neoplasm, Spleen Focus-Forming Viruses, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.